Overview
Cystic fibrosis (CF) is a life-threatening genetic disorder that affects approximately 70,000 people worldwide. It is caused by a mutation in the CFTR gene, which codes for the cystic fibrosis transmembrane conductance regulator protein. This protein plays a crucial role in regulating the transport of salt and water in and out of cells, particularly in the lungs, pancreas, and intestines. In individuals with CF, the defective protein leads to abnormal mucus production, which clogs the airways and traps bacteria, resulting in persistent lung infections and malnutrition.
CF affects people of all ethnicities, but it is most common in people of European ancestry. The disease is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition. Carriers of the mutated gene, who have one normal and one mutated gene, are generally healthy but can pass the mutated gene to their offspring.
History/Background
The first recorded description of cystic fibrosis dates back to 1938, when Dr. William E. Ladd and Dr. Robert E. Hardy described a case of meconium ileus, a condition where the meconium (the first stool of a newborn) is stuck in the small intestine. However, it wasn't until the 1950s and 1960s that the disease was recognized as a distinct entity. In 1959, Dr. Paul di Sant'Agnese and his colleagues identified the CFTR gene as the cause of cystic fibrosis.
Key Information
Key facts about cystic fibrosis include:
* Prevalence: Approximately 70,000 people worldwide have cystic fibrosis.
* Symptoms: Persistent lung infections, malnutrition, and pancreatitis (inflammation of the pancreas).
* Complications: Respiratory failure, malnutrition, and osteoporosis.
* Treatment: Pulmonary therapy, enzyme replacement therapy, and lung transplantation.
* Genetic testing: Available for prenatal diagnosis and carrier screening.
Significance
Cystic fibrosis is a significant public health concern due to its high mortality rate and significant healthcare costs. The disease affects not only the individual but also their family and caregivers. Advances in genetic research and treatment options have improved the quality of life for people with CF, but more research is needed to find a cure for this devastating disease.
